SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stuart C. Gordon, Lois E. Lamerato, Loralee B. Rupp, Jia Li, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Vinutha Vijayadeva, Joseph A. Boscarino, Emily M. Henkle, Nancy Oja–Tebbe, Mei Lu, Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population, Clinical Gastroenterology and Hepatology, 2014, 12, 5, 885

    CrossRef

  2. 2
    Chun-Ying Wu, Jaw-Town Lin, Hsiu J. Ho, Chien-Wei Su, Teng-Yu Lee, Shen-Yung Wang, Chuhui Wu, Jaw-Ching Wu, Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study, Gastroenterology, 2014, 147, 1, 143

    CrossRef

  3. 3
    Y.-C. Hsu, C.-Y. Wu, H.-Y. Lane, C.-Y. Chang, C.-M. Tai, C.-H. Tseng, G.-H. Lo, D.-S. Perng, J.-T. Lin, L.-R. Mo, Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2014, 69, 7, 1920

    CrossRef

  4. 4
    Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada, Reply, Hepatology, 2014, 59, 5